Ironwood Pharmaceuticals | Pasivo Circulante



Current Liabilities Cambio Fecha
Acadia Pharmaceuticals USD 394.87M 50.92M 2024-12
Agios Pharmaceuticals USD 81.16M 38.3M 2024-12
Almirall EUR 274.01M 14.41M 2024-06
Alnylam Pharmaceuticals USD 1.19B 34.39M 2024-12
Amarin USD 201.55M 28.99M 2024-09
Ardelyx USD 77.83M 7.33M 2024-12
Astellas Pharma JPY 1.15T 59.2B 2024-12
AstraZeneca USD 27.87B 1.94B 2024-12
Charles River Laboratories USD 994.1M 18.12M 2024-12
Exact Sciences USD 732.19M 8.52M 2024-12
Halozyme Therapeutics USD 139.1M 30.28M 2024-12
Incyte USD 1.64B 140.2M 2024-12
Ironwood Pharmaceuticals USD 39.15M 10.24M 2024-12
MacroGenics USD 59.31M 1.4M 2024-09
Moderna USD 2.21B 5M 2024-12
Myriad Genetics USD 164.1M 9.8M 2024-12
Pacira USD 309.92M 3.52M 2024-12
PTC Therapeutics USD 580.98M 29.73M 2024-12
Sarepta Therapeutics USD 731.68M 32.2M 2024-12
Takeda JPY 2.1T 289.27B 2024-12
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12



Ironwood Pharmaceuticals Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.